[Use of levodopa, pyrroxan and etimizol in treating tonsillogenic cardiomyopathy].
Dutka
R Ia
RIa
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D004146:Dioxanes / Q000627:therapeutic use*; D004147:Dioxins / Q000627:therapeutic use*; D004341:Drug Evaluation; D005042:Etimizol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D014069:Tonsillitis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D007093:Imidazoles; D007980:Levodopa; D005042:Etimizol; C009143:proroxan
Primenenie levodopy, pirroksana i étimizola v lechenii tonzillogennoĭ kardiomiopatii.